|
Theoretically, if the Hera trial touts a 46% reduction in recurrence, then the results should be as follows:
ER/PR neg, Her2+
node negative - 9.72%
1-3 nodes - 13.5%
greater than 4 nodes - 17.8%
ER/PR+, Her2+
node negative - 4.86%
1-3 nodes - 6.48%
greater than 4 nodes - 17.8%
This is just doing the straight math on my part and using the numbers you provided below.
If anybody has the real thing, it would be interesting as the Hera study does publish that the reduction in recurrence at 2 yrs of 46% so... these numbers should be similar with the exception of rounding up or down.
Best regards,
Becky
|